Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPAT4 antisense RNA 1 (GPAT4-AS1, also known as GIAT4RA) is a human long non-coding RNA gene transcribed from the antisense strand of the GPAT4 locus. Like other antisense RNAs, it does not code for a protein but instead functions at the RNA level. Recent evidence indicates that GPAT4-AS1 acts as a tumor suppressor in non-small cell lung cancer, inhibiting cancer cell proliferation or progression. Antisense lncRNAs are thought to regulate their sense gene partners, or other downstream targets, through a variety of mechanisms including transcript interference, RNA-RNA duplex formation, and chromatin remodeling. There are currently no targeted drugs or recognized biomarkers for GPAT4-AS1, but it is under investigation as a potential therapeutic target and disease modulator, most notably in cancer biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPAT4 antisense RNA 1 (GPAT4-AS1).